A Strength-based Parenting Program for Parents With Young Children From 3 to 6 Years Old

September 1, 2026 updated by: Anna Na Na Hui, City University of Hong Kong

KeySteps@JC Phase Two Parenting Program

The parent education and family support component in phase 2 aims to strengthen protective factors of healthy child development and reduce risk factors of child abuse and neglect among disadvantaged families by providing community-based preventive interventions for children and their significant adults.

Participants include about 600 parents from randomly assigned 100 preschools to the four groups (group 1: hub + school support; group 2: school support; group 3: hub support; group 4: delay group).

The primary hypothesis is to examine the efficacy of the parenting programs for young children and their parents from K1 to K3. The programs are delivered by social workers at kindergartens or community hubs. The second aim/hypothesis of this project is to investigate the overall synergy impact of the community hub.

The success of the parent-child interactive program offers a foundation for the hub to further develop community-based parent education and family support programs that aim at building parents/caregivers' competence in optimizing child development and competence in caregivers and professionals through networking multiple ecological systems, i.e., family, school, and hub or other organizations in the community.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Community hubs could be scaled up as a key setting where majority of intervention shall take place in to build capacity of significant others. For instance, there it will be an arena for the community-based parent education and family support programs. Community hubs act as a connector to bridge services. Due to disparity in resources and knowledge, parents in poverty may need extra rapport to bridge them to various supportive services available in the hub/community for the children's optimum development. This child and family centered approach can help foster community cohesion and raise family and children well-being.

The parenting program is designed with an emphasis on strength-based parenting practice and both children and parents have parallel sessions on the same character strength and also joint sessions to optimize the impact. Both quantitative and qualitative data will be collected.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
600

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Hong Kong
      • Hong Kong, Hong Kong
        • City University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • parents whose children study in the 100 preschools taking part in the project

Exclusion Criteria:

  • parents who do not give consent to take part

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Parent-Child Parallel Program in school and hub
It is an intervention for Parent-Child Parallel Program in both school and hub.
Behavioral: The Strength-based parenting program
A parenting program is designed with strength-based parenting theory and practice. It has 6 sessions for parents and young children when the children are at 3 years old, 4 sessions for them at 4 years old and another 4 sessions for them at 5 years old.
Active Comparator: Parent-Child Parallel Program in school
The program is delivered in school.
Behavioral: The Strength-based parenting program
A parenting program is designed with strength-based parenting theory and practice. It has 6 sessions for parents and young children when the children are at 3 years old, 4 sessions for them at 4 years old and another 4 sessions for them at 5 years old.
Active Comparator: Parent-Child Parallel Program in hub
The parenting program is delivered in hub.
Behavioral: The Strength-based parenting program
A parenting program is designed with strength-based parenting theory and practice. It has 6 sessions for parents and young children when the children are at 3 years old, 4 sessions for them at 4 years old and another 4 sessions for them at 5 years old.
Active Comparator: Parent-Child Parallel Program with a delayed format
The parenting program will be delivered in a delayed format
Behavioral: The Strength-based parenting program
A parenting program is designed with strength-based parenting theory and practice. It has 6 sessions for parents and young children when the children are at 3 years old, 4 sessions for them at 4 years old and another 4 sessions for them at 5 years old.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change in early parenting attitude
Time Frame: From enrollment to the end of treatment at 4-6 months
1 indicates the lowest scores and 7 indicates the highest scores in affection and attachment between parents and children.
From enrollment to the end of treatment at 4-6 months
Change in strength-based parenting practice
Time Frame: From enrollment to the end of treatment at 6 months
1 indicates lowest use of strength-based parenting practice and 7 indicates highest use of strength-based parenting practice
From enrollment to the end of treatment at 6 months
Change in child and parent relationship
Time Frame: From enrollment to the end of treatment at 4-6 months
1 indicates the lowest scores and 5 indicates the highest scores in closeness and conflicts
From enrollment to the end of treatment at 4-6 months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Change in synergy impact of inter-sectors
Time Frame: From enrollment to the end of treatment at 4-6 months
1 indicates the lowest score and 5 indicates the highest scores in synergy impact
From enrollment to the end of treatment at 4-6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
City University of Hong Kong

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
The University of Hong Kong
Education University of Hong Kong
Tung Wah Group of Hospitals
Hong Kong Christian Service
The Boys' and Girls' Clubs Association of Hong Kong

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Anna Hui, PhD, City University of Hong Kong

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 1, 2022

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 31, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 31, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 2, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 2, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 9, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 3, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 1, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • KeySteps@JCStrength-BasedStudy
  • 2022-0114-007 (Other Grant/Funding Number: Hong Kong Jockey Club Charities Trust)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

It is because the participants do not give right to share their data with researchers not in the study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings